Glancy Prongay & Murray LLP Announces Investigation on Behalf of EverQuote, Inc. Investors

Donnerstag, 14.03.19 22:48
Glancy Prongay & Murray LLP Announces Investigation on Behalf of EverQuote, Inc. Investors
Bildquelle: iStock by Getty Images
LOS ANGELES –

Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of EverQuote, Inc. investors (“EverQuote” or the “Company”) (NASDAQ: EVER) concerning the Company and its officers’ possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, at 310-201-9150, Toll-Free at 888-773-9224, or by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com.

On or about June 18, 2018, EverQuote sold 4.69 million shares of stock in its initial public stock offering (the “IPO”), at $18 a share raising $84,375,000 in new capital. EverQuote's first public earnings report revealed that second quarter 2018 quote request volume had worsened to a year-over-year growth rate of only 2.3%—down from 14.3% touted in the IPO registration statement—and to a quarterly decline of 12%. Then, in November 2018, EverQuote revealed that quote request volume had worsened to zero growth, causing the Company's stock to drop significantly.

If you purchased EverQuote securities, have information, or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, CA 90067 at 310-201-9150, Toll-Free at 888-773-9224, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number, and the number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.



Quelle: Business Wire


News und Analysen

INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Diplomat Pharmacy, Inc. and Encourages Investors to Contact the Firm Before April 25

NEW YORK – The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California ...weiterlesen

Seite: 1 | 2 | 3 | 4 | 5 | 6 | ... | 10888